Obtaining anti-HCP antibodies is the critical step in the development of a specific process or platform ELISA. Indeed, it is advisable to obtain an antibody recognition recovery of at least 70% of PHCs, evenly distributed at the molecular weight and charge (pI) level.
In order to obtain these antibodies recognizing the greatest diversity of HCPs, work on the choice and preparation of the immunogen and the implementation of specific immunization strategies is necessary.
Materials to provide
Information about the project.
Further details on the project may be requested.
You will be able to exchange directly with the experts after filling in the form below.
Typical deliverables
Specific anti-HCP antibodies.
Supply risk management.
Study following the specifications validated with the Expert.
Get started with your development of anti-HCP antibodies
Please answer the fields below to be contacted by our team of scientists
